EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 0.6050
-0.1150 (-15.97%)
At close: Sep 11, 2026
EXACT Therapeutics AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -75.79 | -86.97 | -52.33 | -48.33 | -40.1 | -58.59 |
Depreciation & Amortization | 3.72 | 3.68 | 2.43 | 2.09 | 1.94 | 1.83 |
Stock-Based Compensation | 1.37 | 2.26 | 2.82 | 3.96 | -0.4 | 4.16 |
Other Operating Activities | -1.19 | 2.09 | -0.52 | 0 | -0.21 | -0.52 |
Change in Accounts Receivable | 5.49 | 12.69 | -39.39 | -1.32 | -0.53 | -1.62 |
Change in Accounts Payable | 1.22 | -0.75 | 6.53 | -0.69 | 5.46 | 0.74 |
Change in Other Net Operating Assets | - | - | -0.08 | -0 | - | -1.11 |
Operating Cash Flow | -65.19 | -66.99 | -80.55 | -44.3 | -33.85 | -55.11 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.87 | -5.32 | -1.51 | -3.09 | -0.25 | -1.63 |
Investment in Securities | - | - | - | - | 20.37 | - |
Other Investing Activities | 1.24 | 2.62 | 0.92 | 0.95 | 0.48 | 0.62 |
Investing Cash Flow | -0.63 | -2.7 | -0.58 | -2.15 | 20.6 | -1.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.76 | -0.6 | -0.58 | -0.51 | -0.44 |
Lease Payments | -0.82 | -0.76 | -0.6 | -0.58 | -0.51 | -0.44 |
Net Debt Issued (Repaid) | -0.82 | -0.76 | -0.6 | -0.58 | -0.51 | -0.44 |
Issuance of Common Stock | 59.39 | - | 129.46 | 25 | 0.1 | 0.51 |
Other Financing Activities | -2.1 | -0.03 | 5.47 | -1.25 | -0.12 | -0.12 |
Financing Cash Flow | 56.46 | -0.8 | 134.33 | 23.17 | -0.53 | -0.05 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.04 | -4.7 | -0.1 | 0.32 | 0.26 | -0.15 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - |
Net Cash Flow | -9.4 | -75.19 | 53.11 | -22.96 | -13.52 | -56.31 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -67.06 | -72.31 | -82.05 | -47.39 | -34.1 | -56.74 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -85976.39% | -122558.79% | - | -1062987.39% | -7503.15% | -109106.39% |
Free Cash Flow Per Share | -0.77 | -1.14 | -2.37 | -1.48 | -1.14 | -1.89 |
Levered Free Cash Flow | -57.1 | -55.69 | -31.46 | -29.35 | -19.34 | -34.63 |
Unlevered Free Cash Flow | -57.08 | -55.67 | -31.43 | -29.29 | -19.27 | -34.57 |
Free Cash Flow After Leases | -67.89 | -73.07 | -82.65 | -47.97 | -34.61 | -57.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.03 | 0.03 | 0.05 | 0.09 | 0.1 | 0.1 |
Change in Working Capital | 6.71 | 11.94 | -32.94 | -2.02 | 4.92 | -1.99 |